Alzheimer’s disease is a neurological degenerative disorder and the eighth leading cause of death in the United States. It affects approximately 6.2 million people, with annual healthcare costs amounting to around $305 billion [1]. The disease is characterized by abnormal protein synthesis, leading to neuroinflammation and damage to nerve cells. This results in hindrances to…
MSC CM Potential for Alzheimer’s Disease Treatment






